Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.
Evidence supports the potential for e-prescribing to reduce the incidence of adverse drug events (ADEs) in hospital-based studies, but studies in the ambulatory setting have not used occurrence of ADE as their outcome. Using the "prescription origin code" in 2011 Medicare Part D prescription drug events files, the authors investigate whether physicians who meet the meaningful use stage 2 threshold for e-prescribing (≥50% of prescriptions e-prescribed) have lower rates of [...]
Author(s): Powers, Christopher, Gabriel, Meghan Hufstader, Encinosa, William, Mostashari, Farzad, Bynum, Julie
DOI: 10.1093/jamia/ocv036